Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.

× No keyword cloud information.

22 in total

1. G484S amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate.

Authors: Laura Rodero; Emilia Mellado; A Carolina Rodriguez; Angela Salve; Liliana Guelfand; Pedro Cahn; Manuel Cuenca-Estrella; Graciela Davel; Juan L Rodriguez-Tudela
Journal: Antimicrob Agents Chemother Date: 2003-11 Impact factor: 5.191

2. Combination efficacy of voriconazole and amphotericin B in the experimental disease in immunodeficient mice caused by fluconazole-resistant Cryptococcus neoformans.

Authors: Eriques Gonçalves Silva; Claudete Rodrigues Paula; Amanda Latercia Tranches Dias; Marilene Rodrigues Chang; Luciana da Silva Ruiz; Valderez Gambale; Renato Araujo Prates; Martha Simões Ribeiro
Journal: Mycopathologia Date: 2010-10-24 Impact factor: 2.574

3. Antifungal therapy in a murine model of disseminated infection by Cryptococcus gattii.

Authors: Enrique Calvo; F Javier Pastor; M Mar Rodríguez; Isabel Pujol; Josep Guarro
Journal: Antimicrob Agents Chemother Date: 2010-07-12 Impact factor: 5.191

4. Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14α-demethylase (Erg11) residue critical for differential susceptibility between fluconazole/voriconazole and itraconazole/posaconazole.

Authors: Edward Sionov; Yun C Chang; H Martin Garraffo; Michael A Dolan; Mahmoud A Ghannoum; Kyung J Kwon-Chung
Journal: Antimicrob Agents Chemother Date: 2011-12-12 Impact factor: 5.191

5. Cryptococcus neoformans ADS lyase is an enzyme essential for virulence whose crystal structure reveals features exploitable in antifungal drug design.

Authors: Jessica L Chitty; Kirsten L Blake; Ross D Blundell; Y Q Andre E Koh; Merinda Thompson; Avril A B Robertson; Mark S Butler; Matthew A Cooper; Ulrike Kappler; Simon J Williams; Bostjan Kobe; James A Fraser
Journal: J Biol Chem Date: 2017-05-30 Impact factor: 5.157

6. Role of AFR1, an ABC transporter-encoding gene, in the in vivo response to fluconazole and virulence of Cryptococcus neoformans.

Authors: Maurizio Sanguinetti; Brunella Posteraro; Marilena La Sorda; Riccardo Torelli; Barbara Fiori; Rosaria Santangelo; Giovanni Delogu; Giovanni Fadda
Journal: Infect Immun Date: 2006-02 Impact factor: 3.441

7. Comparative analysis of the Vitek 2 antifungal susceptibility system and E-test with the CLSI M27-A3 broth microdilution method for susceptibility testing of Indian clinical isolates of Cryptococcus neoformans.

Authors: Aarti Tewari; Bijayani Behera; Purva Mathur; Immaculata Xess
Journal: Mycopathologia Date: 2012-02-22 Impact factor: 2.574

Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.